Fate Therapeutics Inc. (FATE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Fate Therapeutics Inc.

    NASDAQ: FATE · Real-Time Price · USD
    1.01
    0.04 (3.81%)
    At close: Sep 05, 2025, 3:59 PM
    1.01
    0.00%
    After-hours: Sep 05, 2025, 06:17 PM EDT

    Fate Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 13.63M 63.53M 96.3M 55.85M
    Cost of Revenue
    		 18.96M 18.28M 13.76M 5.85M
    Gross Profit
    		 13.63M -93.65M 82.54M 50M
    Operating Income
    		 -210.28M -190.51M -308.39M -216.99M
    Interest Income
    		 17.29M 17.19M 5.84M 1.31M
    Pretax Income
    		 -186.26M -160.93M -281.72M -212.15M
    Net Income
    		 -186.26M -160.93M -281.72M -212.15M
    Selling & General & Admin
    		 74.17M 81.45M 84.23M 57.32M
    Research & Development
    		 135M 172.6M 320.45M 215.52M
    Other Expenses
    		 14.74M -157.19M -13.76M -5.85M
    Operating Expenses
    		 223.91M 96.86M 390.93M 266.99M
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 223.91M 254.04M 404.69M 272.84M
    Income Tax Expense
    		 n/a n/a -26.66M -5.85M
    Shares Outstanding (Basic)
    		 113.69M 98.41M 96.83M 94.75M
    Shares Outstanding (Diluted)
    		 113.69M 98.41M 96.83M 94.75M
    EPS (Basic)
    		 -1.64 -1.64 -2.91 -2.24
    EPS (Diluted)
    		 -1.64 -1.64 -2.91 -2.24
    EBITDA
    		 -176.58M -172.23M -294.63M -211.14M
    EBIT
    		 -195.54M -190.51M -308.39M -216.99M
    Depreciation & Amortization
    		 18.96M 18.28M 13.76M 5.85M

    Add to Watchlist